Suppr超能文献

活性位点滴定剂Nα-(N,N-二甲基氨基甲酰基)-α-氮杂赖氨酸对硝基苯酯对人α-凝血酶的抑制作用:一项比较动力学和X射线晶体学研究。

Human alpha-thrombin inhibition by the active site titrant N alpha-(N,N-dimethylcarbamoyl)-alpha-azalysine p-nitrophenyl ester: a comparative kinetic and X-ray crystallographic study.

作者信息

Nardini M, Pesce A, Rizzi M, Casale E, Ferraccioli R, Balliano G, Milla P, Ascenzi P, Bolognesi M

机构信息

Centro Biotecnologie Avanzate IST, Università di Genova, Italy.

出版信息

J Mol Biol. 1996 May 24;258(5):851-9. doi: 10.1006/jmbi.1996.0292.

Abstract

Kinetics for the hydrolysis of the chromogenic active site titrant N alpha-(N,N-dimethylcarbamoyl)-alpha-azalysine p-nitrophenyl ester (Dmc-azaLys-ONp) catalyzed by bovine beta-trypsin, bovine alpha-thrombin, human alpha-thrombin, human Lys77-plasmin, human urinary kallikrein, the M(r) 33,000 and M(r) 54,000 species of human urokinase, as well as by porcine pancreatic beta-kallikrein-A and B have been obtained between pH 6.0 and 8.0, at 21.0 degrees C. Moreover, the three dimensional structure of the human alpha-thrombin-(hirugen).Dmc-azaLys acyl.enzyme complex has been analyzed and refined by X-ray crystallography at 2.0 A resolution (R-factor = 0.168). As observed for bovine beta-trypsin, the acylating inhibitor molecule is covalently bound to the Ser195 catalytic residue, filling the human alpha-thrombin S1 primary specificity subsite with its lysyl side-group. However, the carbonyl group of the scissile human alpha-thrombin.Dmc-azaLys acyl bond does not occupy properly the oxyanion binding hole. At variance from the bovine beta-trypsin.Dmc-azaLys acyl.enzyme structure, a second, not covalently bound, inhibitor molecule, partly shielded by the 60-insertion loop of human alpha-thrombin, is contacting the enzyme "aryl-binding site".

摘要

在21.0℃、pH 6.0至8.0的条件下,已获得牛β-胰蛋白酶、牛α-凝血酶、人α-凝血酶、人Lys77-纤溶酶、人尿激肽释放酶、人尿激酶的Mr 33,000和Mr 54,000亚型以及猪胰β-激肽释放酶-A和-B催化生色活性位点滴定剂Nα-(N,N-二甲基氨基甲酰基)-α-氮杂赖氨酸对硝基苯酯(Dmc-azaLys-ONp)水解的动力学数据。此外,已通过X射线晶体学在2.0 Å分辨率下(R因子= 0.168)对人α-凝血酶-(水蛭素).Dmc-azaLys酰基酶复合物的三维结构进行了分析和精修。正如在牛β-胰蛋白酶中观察到的那样,酰化抑制剂分子与Ser195催化残基共价结合,其赖氨酰侧链填充了人α-凝血酶S1主要特异性亚位点。然而,人α-凝血酶.Dmc-azaLys酰基键的可裂解羰基并未正确占据氧阴离子结合孔。与牛β-胰蛋白酶.Dmc-azaLys酰基酶结构不同,第二个非共价结合的抑制剂分子部分被人α-凝血酶的60插入环屏蔽,正在与人α-凝血酶的“芳基结合位点”接触。

文献AI研究员

20分钟写一篇综述,助力文献阅读效率提升50倍。

立即体验

用中文搜PubMed

大模型驱动的PubMed中文搜索引擎

马上搜索

文档翻译

学术文献翻译模型,支持多种主流文档格式。

立即体验